The main factor driving market growth is the increase in the prevalence of diabetes in the country. India has the second largest number of adults with diabetes in the world. According to the IDF, in 2019 there were 77 million adults (20-79 years) who suffered from diabetes.

Request an example from our report on The diabetes market for medicines in India : https://www.omrglobal.com/request-sample/india-diabetes-care-drugs-market

Moreover, the increase in the aging population is also among one of the main motivations of the Indian pharmaceutical industry for treating diabetes. According to the World Bank, there are more than 83 million elderly population (65 and over) which is over 6.1% of the total population. As older people are more prone to diseases like diabetes, joint pain among other things creates space for the market.

According to IDF forecasts, the prevalence of diabetes is expected to reach more than 101.0 million in 2030 and to reach 134.2 million in 2045. Moreover, the increased spending on health services and especially diabetes may also support market growth over the forecast period. According to the World Economic Forum (WEF), the country’s GDP in 2018 was $ 2.9 trillion. According to India’s National Health Portal, India spends only 1.02% of its GDP on public health. The presence of key players also supports market growth throughout the forecast period.

Market coverage

  • Available market number for – 2019-2026
  • Base year – 2019
  • Forecast period – 2020-2026
  • Segment covered – by the drug department
  • Covered area – India

Competitive landscape – אלי לילי ושות’, Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi SA, Sun Pharmaceuticals Industries Ltd., ו-Takeda Pharmaceuticals Industries Ltd.

A full report of the Diabetes Drug Market in India is available at: https://www.omrglobal.com/industry-reports/india-diabetes-care-drugs-market

The Diabetes Drug Market in India – Segmentation

By drug class

  • Insulins
  • Non-insulin injection drugs
  • Oral antidiabetic drugs
  • Combined drugs

Company profiles

  • AstraZeneca Plc
  • Eli Lilly & Co.
  • Johnson & Johnson Services Inc.
  • Merck & Co. Inc.
  • Miles NV
  • Novo Nordisk A / S
  • Pfizer Ltd.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Deputy

Reasons to buy from us –

  1. We cover more than 15 major industries, segmented into more than 90 sectors.
  2. More than 120 countries are designated for surgery.
  3. More than 100 paid data sources mined for investigation.
  4. Our expert research analysts answer all of your questions before and after purchasing your report.

On Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicate research reports, customized research reports, consulting and other research-based services.

Communication contact:

Company Name: Orion Market Research

Contact: Mr. Anorg Tiwari

Email: [email protected]

Contact number: +91 7803040404

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.